Target intelligence / Profile preview

Intestinal microbiota and host intestinal environment

Molecular classification
Other
01

Overview

The intestinal microbiota and host intestinal environment represent a complex symbiotic ecosystem comprising trillions of microorganisms, including bacteria, fungi, viruses, and archaea, interacting with the host's epithelial and immune cells (Nature, 2016, https://www.nature.com/articles/nature18849). This system plays a critical role in human health by facilitating nutrient metabolism, synthesizing essential vitamins, and training the host immune system to distinguish between commensal and pathogenic organisms (Science, 2012, https://www.science.org/doi/10.1126/science.1223490). Dysregulation of this environment, known as dysbiosis, is linked to a wide range of conditions, including gastrointestinal diseases like Inflammatory Bowel Disease (IBD) and Clostridioides difficile infection (CDI), as well as systemic metabolic and neurological disorders (NIH, 2012, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426293/). Therapeutic interventions aim to restore a healthy microbial balance through the use of antibiotics, probiotics, prebiotics, or fecal microbiota transplantation (FDA, 2023, https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevent-recurrence-clostridioides). Understanding the bidirectional communication between the microbiota and the host is essential for developing targeted therapies that modulate the intestinal environment to improve clinical outcomes.

Other names
Gut microbiotaGut microbiomeIntestinal floraGastrointestinal microbiomeHost-microbe interface
02

Mechanism of action

Modulation of microbial composition, restoration of taxonomic diversity, production of short-chain fatty acids (SCFAs), competitive inhibition of pathogens, and enhancement of host epithelial barrier function.

03

Biological functions

MetabolismImmune responseNutrient absorptionPathogen protectionVitamin synthesisIntestinal barrier maintenance
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeObesityType 2 diabetesClostridioides difficile infectionColorectal cancerMetabolic syndrome
05

Safety considerations

Risk of pathogen transferSystemic translocation of bacteriaInduced dysbiosisLong-term metabolic impactPatient response variability
06

Interacting drugs

Vancomycin

8 more in the full profile.

07

Biomarkers

Alpha diversityBeta diversityFirmicutes/Bacteroidetes ratioFecal calprotectinShort-chain fatty acids (SCFAs)

Beyond the preview

Go deeper on Intestinal microbiota and host intestinal environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal microbiota and host intestinal environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call